Two cardiologists joined Becker’s to discuss the things they find most exciting in the specialty, from emerging technology to new business developments.
Editor’s note: Responses have been lightly edited for clarity and length:
Rajesh Sharma, MD. Cardiologist at Advanced Heart and Vein Center (Thornton, Colo.): New therapies for hypertension, including renal denervation. This adds to our armamentarium for hypertension management. Also, what’s exciting is the evolution of the [ASC] and ability to perform a majority of elective procedures in a safe environment that’s extremely cost-effective.
Amit Singh, MD. Cardiologist at Cayuga Health (Ithaca, N.Y.): [Guideline-directed medical therapy] for [heart failure with reduced ejection fraction] and [heart failure with preserved ejection fraction]. Use it daily for my patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.